已故捐赠者移植的移植存活率与单个移植的移植相比
Molly H White1, Lainie Ross2,3, Amy Gallo4
1Department of Medicine, University of Chicago, Chicago, IL.
Transplantation
|May 22, 2024
概括
从最小的儿科捐赠者获得的 En bloc 脏移植,与顶级单个脏移植相比,1 年的存活率明显较短. 未来的分配系统需要为公平的移植分配提供儿科专用分数.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植手术 移植手术
- 器官分配政策 器官分配政策
背景情况:
- 美国脏分配系统 (KAS) 目前从脏捐赠者个人资料指数 (KDPI) 上20%的捐赠者进行单次脏移植 (SKT) 的捐赠者<18公斤的已故捐赠者脏移植.
- 虽然整体移植通常优于具有相似捐赠者体重的SKT,但来自最小的儿科捐赠者 (<8公斤) 的整体移植与顶级KDPI SKT的性能仍然不清楚.
研究的目的:
- 来自最小的儿科捐赠者 (<8公斤) 和较大的儿科捐赠者 (≥8公斤) 的整体脏移植的移植存活率与来自KDPI前20%捐赠者的SKT进行比较.
- 在当前的美国KAS框架内,评估捐赠者大小对整体移植结果的影响.
主要方法:
- 使用了移植受体科学注册 (SRTR) 数据库.
- 在2021年进行的移植中,与SKT (KDPI前20%),比较了集体移植的捐赠者特征和移植存活率 (最小的<8公斤和较大的≥8公斤) 和SKT (KDPI前20%).
- 分析了使用2010-2012年历史数据的长期存活率,用于最小的捐赠者集体移植和A序列SKT.
主要成果:
- 来自较大的儿科捐赠者 (≥8公斤) 的集体移植显示出与A序列SKT相似的1年生存率 (96%对96%,P=0.9).
- 来自最小的儿科捐赠者 (<8公斤) 的集体移植与A序列SKT相比,显示出显著较低的1年生存率 (80%与96%相比,P<0.01).
- 长期分析 (2010-2012年) 显示,最小的捐赠者集体移植和A序列SKT (69%对64%,P=0.3) 的10年生存率相似.
结论:
- 当前的KAS可能无法充分考虑来自最小儿科捐赠者的集体移植的差异性结果.
- 研究结果表明,需要在KAS内建立一个针对儿科的评分系统,以确保公平的分配和优化移植存活率.
- 实施儿科块的捐赠者特定评分可以改善移植结果和公平性.
相关概念视频
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...


